ELI

Canada
Canada
SEARCH FILTERS
Time filter
Source Type

News Article | May 4, 2017
Site: www.prweb.com

SmarterServices™ and the Engineering Leadership Institute (ELI) have partnered to create a system to evaluate and improve communications, problem solving and collaboration skills for engineers. The SmarterMeasure platform, using questions compiled by ELI, will be an integral part of the ELI Success Enabling Skills™ performance certification system. The SmarterMeasure platform, will first evaluate the Success Enabling Skills competencies of engineering practitioners as they enter the ELI curriculum. Doing so enables learners to build competencies in skills not typically provided by academic institutions or professional development programs. The platform identifies gaps in skill competencies to produce a personalized ELI curriculum. The engineer can then fill those gaps, making them more effective in the workplace and their careers while generating higher operating profits for their organization. After completing the ELI curriculum, SmarterMeasure evaluates the students’ grasp, awareness of, openness to, and the importance they assign to Success Enabling Skills. The performance certification provided by the SmarterMeasure platform provides the basis for web-based digital badging, and establishes a foundation for a lifelong learning journey and overall career success. Randy Wall, P.E., president and founder of ELI, said, “ELI’s partnership with SmarterServices significantly advances our mission to enable the success of individual practitioners as well as the entire engineering industry. Integrating the SmarterMeasure platform into ELI’s Success Enabling Skills performance certification system calibrates and crafts an online curriculum that plugs the troublesome Success Enabling Skills gap for all segments of the engineering industry, and ignites success across all generations of engineering professionals.” Dr. Mac Adkins, CEO and founder of SmarterServices said, “The web-based ELI engineering competency development curriculum is an ideal deployment for the SmarterServices SmarterMeasure platform. It demonstrates how our data-driven products are equally valuable for shaping web-based professional development applications for the private sector, as they are for informing the success of academic institutions’ elearning programs. In this partnership, everyone wins.” About the Engineering Leadership Institute The Engineering Leadership Institute was created to fill the Success Enabling Skills gap in the engineering industry. Randy P. Wall, PE, MPA, and Mary B. Wall, PE have developed a robust, affordable, online curriculum grounded in over 60 years of cumulative experience managing engineers, business ownership, and providing collaborative project management solutions for small to large sized engineering firms. The ELI curriculum includes video-based trainings, performance certification, and digital badging, providing individuals the Success Enabling Skills to succeed and excel in the workplace, while equipping organizations to empower and engage their employees, improve customer loyalty, and significantly improve operating profits. About SmarterServices LLC SmarterServices provides SmarterAssessments assessment platform, SmarterMeasure - suite of readiness assessments, and SmarterProctoring a multi-dimensional proctoring tool and service that empower nearly 600 educational institutions—K-12 schools, colleges, universities—to organize and analyze relevant data about students. Our data-driven solutions include assessments that measure learner readiness (elearning, competency based education, teaching with technology, non-cognitive and cognitive skills, as well as an exam proctoring management tool. Thus, clients can more intelligently form strategic plans, maximize efficiency, and foster formative learning. Since 2002, over 4 million students have benefited from SmarterServices.


— The Global Playground Equipment Market by Manufacturers, Regions, Type and Application, Forecast to 2022 is a professional and depth research report on Playground Equipment industry that would help to know the world's major regional market conditions of Playground Equipment Market, is the main region including North American, Europe and Asia etc., and the main country including United States, Germany, Japan and China etc.. Browse 206 Tables and Figures, 16 Companies, spread across 124 pages available at http://www.reportsnreports.com/contacts/discount.aspx?name=959054. The report firstly introduced Playground Equipment basic information including Playground Equipment definition, introduction, product scope, market overview, market opportunities, market risk, and market driving force. The report analyzes the top manufacturers of Playground Equipment, with sales, revenue, and price of Playground Equipment, in 2017 and 2017. The Playground Equipment Market report shows the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2017 and the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017. The Playground Equipment Market report shows the different companies Business Overview, Tire Types and Applications and Playground Equipment Market Segment by Type. Scope of the Report: This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers - PlayCore, Landscape Structures, Kompan, Inc, PlayPower, ELI, Henderson, e.Beckmann, SportsPlay, Childforms, Kaiqi, ABC Team, and DYNAMO Place an Order for this Report at http://www.reportsnreports.com/purchase.aspx?name=959054. Market Segment by Type, covers- Monkey Bars, Sandbox, Climbing Equipment, Swings and Slides, Balance Equipment, Motion and Spinning, Others Market Segment by Applications, can be divided into Commercial Playgrounds, Adult Outdoor Fitness Equipment, Theme Play Systems, Others List of Tables and Figures Figure Playground Equipment Picture Table Product Specifications of Playground Equipment Figure Global Sales Market Share of Playground Equipment by Types in 2016 Table Playground Equipment Types for Major Manufacturers Figure Monkey Bars Picture Figure Sandbox Picture Figure Climbing Equipment Picture Figure Swings and Slides Picture Figure Balance Equipment Picture Figure Motion and Spinning Picture Figure Others Picture Table Playground Equipment Sales Market Share by Applications in 2016 Figure Commercial Playgrounds Picture Figure Adult Outdoor Fitness Equipment Picture Figure Theme Play Systems Picture Figure Others Picture And More.. Complete Table of Content is Available at http://www.reportsnreports.com/reports/959054-global-playground-equipment-market-by-manufacturers-countries-type-and-application-forecast-to-2022.html. About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. For more information, please visit http://www.reportsnreports.com/reports/959054-global-playground-equipment-market-by-manufacturers-countries-type-and-application-forecast-to-2022.html


— This report studies the Playground Equipment market. This report mainly focuses on the playground equipment used in commercial playgrounds, adult outdoor fitness equipment, theme play systems, etc. This report focuses on the Playground Equipment in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. For more information or any query mail at sales@wiseguyreports.com Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Monkey Bars Sandbox Climbing Equipment Swings and Slides Balance Equipment Motion and Spinning Others Market Segment by Applications, can be divided into Commercial Playgrounds Adult Outdoor Fitness Equipment Theme Play Systems Others Complete Report Details @ https://www.wiseguyreports.com/reports/1187208-global-playground-equipment-market-by-manufacturers-countries-type-and-application-forecast There are 15 Chapters to deeply display the global Playground Equipment market. Chapter 2, to analyze the top manufacturers of Playground Equipment, with sales, revenue, and price of Playground Equipment, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; 2 Manufacturers Profiles 2.1 PlayCore 2.1.1 Business Overview 2.1.2 Playground Equipment Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 PlayCore Playground Equipment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Landscape Structures 2.2.1 Business Overview 2.2.2 Playground Equipment Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Landscape Structures Playground Equipment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Kompan, Inc 2.3.1 Business Overview 2.3.2 Playground Equipment Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Kompan, Inc Playground Equipment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 PlayPower 2.4.1 Business Overview 2.4.2 Playground Equipment Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 PlayPower Playground Equipment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 ELI 2.5.1 Business Overview 2.5.2 Playground Equipment Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 ELI Playground Equipment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Henderson 2.6.1 Business Overview 2.6.2 Playground Equipment Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Henderson Playground Equipment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 e.Beckmann 2.7.1 Business Overview 2.7.2 Playground Equipment Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 e.Beckmann Playground Equipment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 SportsPlay 2.8.1 Business Overview 2.8.2 Playground Equipment Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 SportsPlay Playground Equipment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Childforms 2.9.1 Business Overview 2.9.2 Playground Equipment Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 Childforms Playground Equipment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Kaiqi 2.10.1 Business Overview 2.10.2 Playground Equipment Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 Kaiqi Playground Equipment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 ABC Team 2.11.1 Business Overview 2.11.2 Playground Equipment Type and Applications 2.11.2.1 Type 1 2.11.2.2 Type 2 2.11.3 ABC Team Playground Equipment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 DYNAMO 2.12.1 Business Overview 2.12.2 Playground Equipment Type and Applications 2.12.2.1 Type 1 2.12.2.2 Type 2 2.12.3 DYNAMO Playground Equipment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Playground Equipment Market Competition, by Manufacturer 3.1 Global Playground Equipment Sales and Market Share by Manufacturer 3.2 Global Playground Equipment Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Playground Equipment Manufacturer Market Share 3.3.2 Top 6 Playground Equipment Manufacturer Market Share 3.4 Market Competition Trend For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


Dublin, April 17, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets" report to their offering. The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021. This report is designed to provide an in-depth look at the therapeutic and diagnostic options of various gastrointestinal disorders. The geographic scope of the report is global, with particular emphasis on the key markets such as the U.S. and the European Union Five (EU5). The estimated market data is also global in nature, with geographic segments such as the U.S., EU and Rest of the World (ROW). The report provides a brief overview of the gastrointestinal system, which provides an introduction to the disorders of the gastrointestinal system; cites risk factors, where applicable; presents current pharmaceutical treatments, market size and key market participants (both prescription and OTC); and presents potential treatments in R&D, potential market size and future market entrants. This report provides: - An overview of the global markets for gastrointestinal therapeutics and diagnostics. - Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021. - Analyses of therapeutics currently on the market as well as potential products and classes of products that are likely to have a significant impact. - Descriptions of the industry in detail, its relationship to the healthcare industry, its participants, and its trends for the future. - Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities. - Profiles of major players in the industry. The market for gastrointestinal pharmaceuticals is divided into two general segments: prescription gastrointestinal pharmaceuticals and OTC gastrointestinal pharmaceuticals. Similarly, the market for gastrointestinal diagnostics, testing and vaccines is divided into three general segments: - Diagnostics and testing market. - Medical devices (endoscopy) - Vaccines. The market is further broken down into the drugs to treat specific disorders within the gastrointestinal system, including the following: - Gastrointestinal tract disorders. - Gastrointestinal tract walls disorders. - Gastrointestinal motility disorders. - Gastrointestinal cancers. Each sub-segment is covered in detail, describing the disorders and diseases, identifying currently available and potential products, and competitors. Key Topics Covered: 1: Introduction Complimentary - Study Goals And Objectives - Reasons For Doing The Study - Intended Audience - Scope Of Report - Methodology And Information Sources 2: Executive Summary - Gastrointestinal Therapeutics And Diagnostics 3: Overview - Gastric Cancer - Inflammatory Bowel Disease (IBD) - Constipation - Opioid-Induced Constipation - Gastroesophageal Reflux Disease 4: Etiology - Anatomy And Physiology Of The Gastrointestinal System - The Enteric Nervous System: An Overview - Factors Affecting The Functioning Of The GI System - Physiology Of The Gi System And The Role Of Each Part In The Gi Process 5: Prescription Therapy Market - Antidiarrheals - Antiemetics - Gastrointestinal Cancer Treatments - Gastroesophageal Reflux Disease Treatments - Proton Pump Inhibitors - Laxatives - Bowel Anti-Inflammatory - Other GI Drugs 6: OTC Therapy Market - Antacids - Locally Acting Antidiarrheals - H2 Inhibitors - Proton Pump Inhibitors - Laxatives - Total OTC Gastrointestinal Drug Market Size And Growth 7: Diagnostics And Devices Market - Enteric Disease Testing Methods - Global Market For Enteric Diagnostic Tests - Campylobacter - Norovirus - Rotavirus - Giardia Parasite - E. Coli - Cryptosporidium - Shigella - Typhoid - Amebiasis - Cholera - Other (H. Pylori, Yersinia) Diagnostic Tests - Medical Devices (Endoscopy) 8: Gastrointestinal Product Pipeline - Therapies For Treating Gastric Cancer - Gerd And Peptic Ulcers - Therapies For Treating IBS - Therapies For Treating Ulcerative Colitis And Crohn'S Disease 9: Patents 10: Company Profiles - Allergan Plc - Ardelyx Inc. - Astellas Pharma Inc. - Astrazeneca - Celgene Corp. - Clovis Oncology - Daewoong Pharmaceutical Co., Ltd. - ELI Lilly And Company - Glaxosmithkline - Horizon Pharma Plc - Immunogenx - Immunomedics - Merck & Co. - Merrimack Pharmaceuticals Inc. - New Link Genetics - Otsuka Holdings Co. Ltd. - Pfizer Inc. - Roche - Sanofi - Shire - Sucampo Pharmaceuticals Inc. - Synergy Pharmaceuticals Inc. - Synthetic Biologics - Taiho Pharmaceutical Co., Ltd. - Takeda Pharmaceuticals - Valeant Pharmaceuticals For more information about this report visit http://www.researchandmarkets.com/research/wqkmrj/gastrointestinal


Flash Physics is our daily pick of the latest need-to-know developments from the global physics community selected by Physics World's team of editors and reporters Sandra Faber has won the 2017 Gruber Foundation Cosmology Prize for her significant contributions to the modern understanding of galaxies and dark matter. Worth $500,000, the prestigious prize was established in 2000 and honours scientists whose discoveries have led to fundamental advancements in cosmology. Faber holds emeritus positions at the University of California, Santa Cruz and the University of California Observatories, and has made many groundbreaking discoveries over the course of her four-decade career. For example, in 1979 she presented a comprehensive review for the evidence of dark matter that is now considered the turning point of the field. Her later theory of how cold dark matter could explain the structure and behaviour of galaxies now underpins modern understanding of galaxy formation. Faber also discovered that every large galaxy has a supermassive black hole at its centre and played a major role in the development of the 10 m Keck telescope in Hawaii and the Wide-Field Camera for the Hubble Space Telescope. The Gruber Foundation will present Faber with the prize money and a gold laureate medal during a ceremony in the autumn. She joins an elite group of winners including the Laser Interferometer Gravitational Wave (LIGO) scientists who made the first detection of gravitational waves and 2006 Nobel Prize winner John Mather for confirming the universe began with a hot Big Bang. Faber is only the third woman to be a named recipient of the award out of 33 winners in total (not including research groups) and was chosen by a male-only advisory board. The transformation of a quantum monopole into a Dirac monopole has been observed for the first time by physicists at Amherst College in the US and Aalto University in Finland. Magnetic monopoles – entities that possess only a north or a south magnetic pole – were predicted 80 years ago by Paul Dirac. While isolated monopoles have never been seen, physicists have been able to create several different collective excitations in condensed-matter systems that resemble monopoles. Now, a team led by David Hall and Mikko Möttönen has used a Bose–Einstein condensate (BEC) of ultracold rubidium atoms to first create an excitation called a quantum monopole, which takes the form of a topological point defect. The quantum monopole exists in a non-magnetized state of the BEC, but then the team applies a magnetic field to the BEC, causing it to become magnetized. This causes the destruction of the quantum monopole, which is then reborn as a Dirac monopole – an excitation that more closely resembles Dirac's original particle. "I was jumping in the air when I saw for the first time that we get a Dirac monopole from the decay," says Möttönen. "This discovery nicely ties together the monopoles we have been producing over the years." The research is described in Physical Review X. A new way of observing how photons scatter from virtual particles has been proposed by James Koga and Takehito Hayakawa at the National Institutes for Quantum and Radiological Science and Technology in Japan. The pair looked at an effect called Delbrück scattering, whereby photons interact with virtual electron–positron pairs in the presence of the electric field of an atomic nucleus. The effect was first observed in the 1970s, but has proven very difficult to study in isolation because it occurs alongside three other scattering processes that contribute to the elastic scattering of photons from nuclei. Now, Koga and Hayakawa have done calculations that suggest that for certain scattering angles the Delbrück scattering of polarized gamma rays will be 100 times stronger than the three other processes. A potential experiment would involve firing a beam of gamma rays with energy of about 1.1 MeV at a tin target – and Koga and Hayakawa say that this could be done at the Extreme Light Infrastructure – Nuclear Physics (ELI-NP) facility that is being built in Romania. Writing in Physical Review Letters, the pair say that an experiment running at ELI-NP for 76 days could characterize Delbrück scattering to within 1% accuracy. This would provide a new test of quantum electrodynamics and might even reveal new physics beyond the Standard Model. ELI-NP will be fully operational in 2019 and Physics World visited recently to find out how construction is progressing: see "Visiting the most powerful laser in the world".


News Article | May 26, 2017
Site: www.eurekalert.org

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde. The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain' or amplification of more than eight orders of magnitude - which could be likened to amplifying the sound of rustling leaves to that of a jumbo jet - in only two mm of plasma. They used 150 J pulses from the powerful Vulcan laser system at the Science and Technology Facilities Council's Central Laser Facility (CLF). Over the course of two pioneering experiments at the CLF, the scientists worked closely with CLF staff to adapt the Vulcan laser in order that two different colour lasers could exchange energy in a plasma. The measured gain coefficient of 180 cm-1 is more than 100 times larger than achievable from existing high power laser system amplifiers based on solid-state media. The results have been published in the journal Scientific Reports, in an article entitled An ultra-high gain and efficient amplifier based on Raman amplification in plasma. Professor Dino Jaroszynski, of Strathclyde's Department of Physics, led the research. He said: "Raman amplification in plasma is a fascinating concept that combines the ideas of Nobel Physics laureate CV Raman with plasma, optical and laser physics. Here, a relatively long, high-energy laser pulse is made to collide in plasma with a short, very low energy pulse. At the point where they collide they produce a beat wave, much like that of two colliding water waves. The light pressure of the beat pattern drives plasma electrons into a regular pattern or echelon that mimics the beat wave. This multi-layer echelon acts as a very high reflectivity, time-varying mirror that sweeps up the energy of the high energy pulse reflecting it into the low energy pulse, thus amplifying the low energy pulse and compressing its energy into an ultra-short duration pulse of light. "Our results are very significant in that they demonstrate the flexibility of the plasma medium as a very high gain amplifier medium. We also show that the efficiency of the amplifier can be quite large, at least 10%, which is unprecedented and can be increased further. However, it also shows what still needs to be understood and controlled in order to achieve a single stage high-gain, high-efficiency amplifier module. "One example of the challenges that we still face is how to deal with amplification of 'noise' produced by random plasma fluctuations, which is exacerbated by the extremely high gain. This leads to undesirable channels for the energy to go. We are making excellent progress and believe that we are in an excellent position to solve these problems in our next experimental campaigns." Dr Gregory Vieux who led the research team working at the CLF, said: "Plasma is a very attractive medium to work with. It has no damage threshold since it is already a fully broken-down medium, therefore we can use it to amplify short laser pulses without the need for stretching and re-compressing. Another advantage is that further compression during the amplification is theoretically possible. This could pave the way for the development of the next generation of laser systems delivering ultra-intense and ultra-short pulses and at a fraction of the cost of existing lasers. "Still, we are not quite there yet. The scheme relies on controlling the Raman instability. It has such a large growth factor that it can develop and grow from small plasma fluctuations." Laser amplifiers are devices that amplify light. In those that are familiar to us, this is done by synchronising the light emission from electrons in atoms or solid state matter, to make it coherent, which is a necessary step to achieving very high powers. However, very high power lasers at the frontier of technology are limited by damage to their optical components and amplifying media. This makes them very large and very expensive. Plasma, the ubiquitous medium of the universe, offers a way around this limitation because it is very robust and resistant to damage - plasma can be seen as matter that has already been broken down into its smallest constituent elements: electrons and ions. By harnessing waves in plasma we can dramatically reduce the size of laser amplifiers while providing a route to much higher peak powers than possible now, exceeding the petawatt range to possibly reach exawatts. This is a very worthy goal because very intense laser pulses can be used for fundamental studies, such as accelerating particles, helping drive nuclear fusion or even extracting particles from vacuum and recreating the conditions inside stars or the primordial condition of the universe in the laboratory. The highest power lasers in the world will be available for use at three research centres that are part of the European Extreme Light Infrastructure (ELI) project. This €850m project is dedicated to the study of light-matter interactions at the highest intensities and shortest time scales. The laser power at ELI will be 1016 Watts or 5% of the total sun's power that is absorbed on the earth at any time. These lasers will lead to new science and technology that could, for example, transform our understanding of high field physics and result in new radiotherapy modalities for the treatment of cancer. There is a need to reduce the cost of laser technology, which plasma could offer. Plasma may be a route to higher powers to go beyond those available at ELI to reach exawatt powers. The investigation was a collaboration between researchers from Strathclyde, Instituto Superior Técnico (IST) in Lisbon, Queens University Belfast, Ulsan National Institute of Science and Technology (UNIST) in South Korea, Heinrich Heine Universität, Düsseldorf and the Extreme Light Infrastructure in the Czech Republic. It was funded by the Engineering and Physical Sciences Research Council. The Research Excellence Framework 2014, the comprehensive rating of UK universities' research, ranked the University of Strathclyde's Physics research first in the UK, with 96% of output assessed as world-leading or internationally excellent.


News Article | May 26, 2017
Site: phys.org

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain' or amplification of more than eight orders of magnitude - which could be likened to amplifying the sound of rustling leaves to that of a jumbo jet - in only two mm of plasma. They used 150 J pulses from the powerful Vulcan laser system at the Science and Technology Facilities Council's Central Laser Facility (CLF). Over the course of two pioneering experiments at the CLF, the scientists worked closely with CLF staff to adapt the Vulcan laser in order that two different colour lasers could exchange energy in a plasma. The measured gain coefficient of 180 cm-1 is more than 100 times larger than achievable from existing high power laser system amplifiers based on solid-state media. The results have been published in the journal Scientific Reports, in an article entitled An ultra-high gain and efficient amplifier based on Raman amplification in plasma. Professor Dino Jaroszynski, of Strathclyde's Department of Physics, led the research. He said: "Raman amplification in plasma is a fascinating concept that combines the ideas of Nobel Physics laureate CV Raman with plasma, optical and laser physics. Here, a relatively long, high-energy laser pulse is made to collide in plasma with a short, very low energy pulse. At the point where they collide they produce a beat wave, much like that of two colliding water waves. The light pressure of the beat pattern drives plasma electrons into a regular pattern or echelon that mimics the beat wave. This multi-layer echelon acts as a very high reflectivity, time-varying mirror that sweeps up the energy of the high energy pulse reflecting it into the low energy pulse, thus amplifying the low energy pulse and compressing its energy into an ultra-short duration pulse of light. "Our results are very significant in that they demonstrate the flexibility of the plasma medium as a very high gain amplifier medium. We also show that the efficiency of the amplifier can be quite large, at least 10%, which is unprecedented and can be increased further. However, it also shows what still needs to be understood and controlled in order to achieve a single stage high-gain, high-efficiency amplifier module. "One example of the challenges that we still face is how to deal with amplification of 'noise' produced by random plasma fluctuations, which is exacerbated by the extremely high gain. This leads to undesirable channels for the energy to go. We are making excellent progress and believe that we are in an excellent position to solve these problems in our next experimental campaigns." Dr Gregory Vieux who led the research team working at the CLF, said: "Plasma is a very attractive medium to work with. It has no damage threshold since it is already a fully broken-down medium, therefore we can use it to amplify short laser pulses without the need for stretching and re-compressing. Another advantage is that further compression during the amplification is theoretically possible. This could pave the way for the development of the next generation of laser systems delivering ultra-intense and ultra-short pulses and at a fraction of the cost of existing lasers. "Still, we are not quite there yet. The scheme relies on controlling the Raman instability. It has such a large growth factor that it can develop and grow from small plasma fluctuations." Laser amplifiers are devices that amplify light. In those that are familiar to us, this is done by synchronising the light emission from electrons in atoms or solid state matter, to make it coherent, which is a necessary step to achieving very high powers. However, very high power lasers at the frontier of technology are limited by damage to their optical components and amplifying media. This makes them very large and very expensive. Plasma, the ubiquitous medium of the universe, offers a way around this limitation because it is very robust and resistant to damage - plasma can be seen as matter that has already been broken down into its smallest constituent elements: electrons and ions. By harnessing waves in plasma we can dramatically reduce the size of laser amplifiers while providing a route to much higher peak powers than possible now, exceeding the petawatt range to possibly reach exawatts. This is a very worthy goal because very intense laser pulses can be used for fundamental studies, such as accelerating particles, helping drive nuclear fusion or even extracting particles from vacuum and recreating the conditions inside stars or the primordial condition of the universe in the laboratory. The highest power lasers in the world will be available for use at three research centres that are part of the European Extreme Light Infrastructure (ELI) project. This €850m project is dedicated to the study of light-matter interactions at the highest intensities and shortest time scales. The laser power at ELI will be 1016 Watts or 5% of the total sun's power that is absorbed on the earth at any time. These lasers will lead to new science and technology that could, for example, transform our understanding of high field physics and result in new radiotherapy modalities for the treatment of cancer. There is a need to reduce the cost of laser technology, which plasma could offer. Plasma may be a route to higher powers to go beyond those available at ELI to reach exawatt powers. Explore further: Researchers developing next generation of high power lasers More information: G. Vieux et al, An ultra-high gain and efficient amplifier based on Raman amplification in plasma, Scientific Reports (2017). DOI: 10.1038/s41598-017-01783-4


This report studies Animal Parasiticides in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Bayer Zoetis Sanofi Boehringer Ingelheim Merck & Co. Novartis AG Ceva Sante Animale ELI Lilly and Company Virbac Perrigo Company Vetoquinol For more information or any query mail at sales@wiseguyreports.com By types, the market can be split into Oral Liquids Tablets Injectables Sprays Other By Application, the market can be split into Animal Home Care By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India Global Animal Parasiticides Market Professional Survey Report 2017 1 Industry Overview of Animal Parasiticides 1.1 Definition and Specifications of Animal Parasiticides 1.1.1 Definition of Animal Parasiticides 1.1.2 Specifications of Animal Parasiticides 1.2 Classification of Animal Parasiticides 1.2.1 Oral Liquids 1.2.2 Tablets 1.2.3 Injectables 1.2.4 Sprays 1.2.5 Other 1.3 Applications of Animal Parasiticides 1.3.1 Animal 1.3.2 Home Care 1.3.3 Application 3 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 2 Manufacturing Cost Structure Analysis of Animal Parasiticides 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Animal Parasiticides 2.3 Manufacturing Process Analysis of Animal Parasiticides 2.4 Industry Chain Structure of Animal Parasiticides 8 Major Manufacturers Analysis of Animal Parasiticides 8.1 Bayer 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Product A 8.1.2.2 Product B 8.1.3 Bayer 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Bayer 2016 Animal Parasiticides Business Region Distribution Analysis 8.2 Zoetis 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Product A 8.2.2.2 Product B 8.2.3 Zoetis 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Zoetis 2016 Animal Parasiticides Business Region Distribution Analysis 8.3 Sanofi 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Product A 8.3.2.2 Product B 8.3.3 Sanofi 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Sanofi 2016 Animal Parasiticides Business Region Distribution Analysis 8.4 Boehringer Ingelheim 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Product A 8.4.2.2 Product B 8.4.3 Boehringer Ingelheim 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Boehringer Ingelheim 2016 Animal Parasiticides Business Region Distribution Analysis 8.5 Merck & Co. 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Product A 8.5.2.2 Product B 8.5.3 Merck & Co. 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Merck & Co. 2016 Animal Parasiticides Business Region Distribution Analysis 8.6 Novartis AG 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Product A 8.6.2.2 Product B 8.6.3 Novartis AG 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Novartis AG 2016 Animal Parasiticides Business Region Distribution Analysis 8.7 Ceva Sante Animale 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Product A 8.7.2.2 Product B 8.7.3 Ceva Sante Animale 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Ceva Sante Animale 2016 Animal Parasiticides Business Region Distribution Analysis 8.8 ELI Lilly and Company 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Product A 8.8.2.2 Product B 8.8.3 ELI Lilly and Company 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 ELI Lilly and Company 2016 Animal Parasiticides Business Region Distribution Analysis For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


News Article | November 8, 2016
Site: marketersmedia.com

— The report firstly introduced Global Cancer Immunotherapy Market including classification, application and industry chain overview; Then we deeply analyzed global growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, demand and industry growth rate etc. • F. Hoffmann-La Roche Ag • Merck & Co., Inc. • Novartis International Ag • GlaxoSmithKline Plc • Amgen Inc. • Bristol-Myers Squibb • ELI Lilly and Company • Celgene Corporation • Seattle Genetics, Inc. • Spectrum Pharmaceuticals, Inc. In the end, the report introduced medical suction device market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Global Cancer Immunotherapy Market. • To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Global Cancer Immunotherapy Market provide insights about factors affecting the market growth • To Analyze the Global Cancer Immunotherapy Market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World (ROW) • To provide country level analysis of the market with respect to the current market size and future prospective • To provide country level analysis of the market for segment by Form, by End-users, and by Application. • To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Cancer Immunotherapy Market Taste the market data and market information presented through more than 100 market data tables and figures spread in 115 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Cancer Immunotherapy Market Research Report – Forecast to 2021” We are thankful for the support and assistance from Global Cancer Immunotherapy Market. Industry chain related technical experts and marketing experts during Research Team survey and interviews. 4 Forecast Indicators 4.1 Introduction 4.2 Growth Drivers 4.2.1 Increasing Incidences of Cancer 4.2.2 Benefit of Immunotherapy Over Other Treatments 4.2.3 Fast Track and Orphan Drug Designations 4.3 Growth Barriers 4.3.1 High Cost of Immunotherapy Treatment 4.5 Macroecnomical Indicators 7 Global Cancer Immunotherapy Market, by Type 7.1 Monoclonal Antibodies 7.1.1 Naked monoclonal Antibodies 7.1.2 Conjugated Monoclonal Antibodies 7.1.3 Bispecific monoclonal antibodies 7.2 Immuno Checkpoints Inhibitors 7.2.1 PD-1/PD-L1 7.2.2 CTLA-4 7.3 Cancer Vaccine 7.3.1 Sipuleucel-T 7.3.2 Others 7.4 Non-Specific Cancer Immunotherapies and Adjuvants Cytokines Interleukins Interferons 7.5 Others 8 Global Cancer Immunotherapy Market, by Region 8.1 North America 8.1.1 USA 8.1.2 Canada 8.2 Europe 8.2.1 Germany 8.2.2 France 8.2.3 U.K. 8.2.4 Rest of Europe 8.3 Asia 8.3.1 India 8.3.2 China 8.3.3 Japan 8.3.4 Rest of Asia 8.4 Rest of the World 10 Company Profiles 10.1 F. Hoffmann-La Roche Ag 10.2 Merck & Co., Inc. 10.3 Novartis International Ag 10.4 Glaxosmithkline Plc 10.5 Amgen Inc. 10.6 Bristol-Myers Squibb 10.7 ELI Lilly and Company 10.8 Celgene Corporation 10.9 Seattle Genetics, Inc. 10.10 Spectrum Pharmaceuticals, Inc. The report for Global Cancer Immunotherapy Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions. APAC Infectious Disease Diagnosis & Treatment Market Information, by applications (Tuberculosis (TB), Aids, Hepatitis B, Hepatitis C and others), by treatment (Antibiotics, antivirals, antifungals, anti-parasitic, alternative medicine and others) by end users (hospitals, clinics, reference labs and others) - Forecast to 2027 At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. For more information, please visit https://www.marketresearchfuture.com


News Article | November 25, 2016
Site: www.newsmaker.com.au

According to Stratistics MRC, the Global Immunotherapy Drugs market is accounted for $38.26 billion in 2015 and is expected to reach $97.47 billion by 2022 growing at a CAGR of 14.3%. In present scenario people are exposed to various harmful conditions which are affecting them through cancer and immunotherapy drugs are helping the people out. Rising cancer therapies coupled with lesser side effects are the factors provoking the market demand. Moreover high prevalence of lifestyle diseases are sustaining the market growth. However, high cost of therapy drugs is major factor restraining the market. Monoclonal antibodies is accounted for largest market share while Checkpoint inhibitors is estimated to be the fastest growing segment on account of its less effect to normal cells compared to ordinary therapeutics. North America commanded the largest market share followed by Europe owing to large government funding in cancer techniques and R&D. Quick drug approvals is also a major factor helping the regional growth. Some of the key players of the Immunotherapy Drugs market include Aduro BioTech Inc, Agenus Inc, Amgen Inc., Bavarian Nordic A/S, Bellicum Pharmaceuticals Inc, Biogen Idec Inc, Bristol-Myers Squibb Company, Celgene Corporation, DenDrit Biotech USA, ELI Lilly and Company, F. Hoffmann-La Roche Ag, Galena Biopharma Inc, Genentech Inc, Glaxosmithkline Plc, Merck & Co., Inc., NewLink Genetics Corp., Novartis International Ag, Oxford BioTherapeutics Ltd., Seattle Genetics, Inc. and Spectrum Pharmaceuticals, Inc.. Drug Types Covered: • Checkpoint Inhibitors • Interferons • Interleukins • Monoclonal Antibodies • Vaccines   Applications Covered: • Blood Cancer • Breast Cancer • Cervical Cancer • Gastric Cancer • Glioblastoma • Lung Cancer • Melanoma • Prostate Cancer   Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK  o Spain      o Rest of Europe  • Asia Pacific o Japan        o China        o India        o Australia        o New Zealand       o Rest of Asia Pacific       • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements

Loading ELI collaborators
Loading ELI collaborators